Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis

Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

(2016) Shigehiko Karino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin

(2016) Kristen E. Fodero et al.   CLINICAL THERAPEUTICS

Management of Acute Kidney Injury and Acid-Base Balance in the Septic Patient

(2016) Paul D. Weyker et al.   CLINICS IN CHEST MEDICINE

Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study

(2016) Drayton A. Hammond et al.   PHARMACOTHERAPY

Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)

(2016) Carole Ichai et al.   Anaesthesia Critical Care & Pain Medicine

Nephrotoxicity Comparison of Two Commercially Available Generic Vancomycin Products

(2015) Jesse D. Sutton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam

(2014) Lindsey D. Burgess et al.   PHARMACOTHERAPY

Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime

(2014) Diane M. Gomes et al.   PHARMACOTHERAPY

Vancomycin-Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors

(2014) Calvin J. Meaney et al.   PHARMACOTHERAPY

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2013) Alessandro Liberati   ANNALS OF INTERNAL MEDICINE

Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with cefepime

(2013) R.P. Moenster et al.   CLINICAL MICROBIOLOGY AND INFECTION

Piperacillin-tazobactam-induced acute interstitial nephritis with possible meropenem cross-sensitivity in a patient with osteomyelitis

(2012) T. J. Liu et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

(2012) S. J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial

(2012) Jens-Ulrik Stæhr Jensen et al.   BMJ Open

Methods for Causality Assessment of Adverse Drug Reactions

(2009) Taofikat B Agbabiaka et al.   DRUG SAFETY